Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Mar 1;277(3):387-396.
doi: 10.1097/SLA.0000000000005698. Epub 2022 Sep 8.

The RECOURSE Study: Long-term Oncologic Outcomes Associated With Robotically Assisted Minimally Invasive Procedures for Endometrial, Cervical, Colorectal, Lung, or Prostate Cancer: A Systematic Review and Meta-analysis

Affiliations
Meta-Analysis

The RECOURSE Study: Long-term Oncologic Outcomes Associated With Robotically Assisted Minimally Invasive Procedures for Endometrial, Cervical, Colorectal, Lung, or Prostate Cancer: A Systematic Review and Meta-analysis

Mario M Leitao Jr et al. Ann Surg. .

Abstract

Objective: To assess long-term outcomes with robotic versus laparoscopic/thoracoscopic and open surgery for colorectal, urologic, endometrial, cervical, and thoracic cancers.

Background: Minimally invasive surgery provides perioperative benefits and similar oncological outcomes compared with open surgery. Recent robotic surgery data have questioned long-term benefits.

Methods: A systematic review and meta-analysis of cancer outcomes based on surgical approach was conducted based on Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines using Pubmed, Scopus, and Embase. Hazard ratios for recurrence, disease-free survival (DFS), and overall survival (OS) were extracted/estimated using a hierarchical decision tree and pooled in RevMan 5.4 using inverse-variance fixed-effect (heterogeneity nonsignificant) or random effect models.

Results: Of 31,204 references, 199 were included (7 randomized, 23 database, 15 prospective, 154 retrospective studies)-157,876 robotic, 68,007 laparoscopic/thoracoscopic, and 234,649 open cases. Cervical cancer: OS and DFS were similar between robotic and laparoscopic [1.01 (0.56, 1.80), P =0.98] or open [1.18 (0.99, 1.41), P =0.06] surgery; 2 papers reported less recurrence with open surgery [2.30 (1.32, 4.01), P =0.003]. Endometrial cancer: the only significant result favored robotic over open surgery [OS; 0.77 (0.71, 0.83), P <0.001]. Lobectomy: DFS favored robotic over thoracoscopic surgery [0.74 (0.59, 0.93), P =0.009]; OS favored robotic over open surgery [0.93 (0.87, 1.00), P =0.04]. Prostatectomy: recurrence was less with robotic versus laparoscopic surgery [0.77 (0.68, 0.87), P <0.0001]; OS favored robotic over open surgery [0.78 (0.72, 0.85), P <0.0001]. Low-anterior resection: OS significantly favored robotic over laparoscopic [0.76 (0.63, 0.91), P =0.004] and open surgery [0.83 (0.74, 0.93), P =0.001].

Conclusions: Long-term outcomes were similar for robotic versus laparoscopic/thoracoscopic and open surgery, with no safety signal or indication requiring further research (PROSPERO Reg#CRD42021240519).

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement

MM Leitao reports personal fees from Johnson and Johnson/Ethicon and Takeda, as well as grants paid to the institution from KCI/Acelity; he is also an ad hoc speaker for Intuitive Surgical, Inc. US Kreaden and AE Hebert are employees of Intuitive Surgical, Inc. BJ Park reports personal fees from Intuitive Surgical Inc. and AstraZeneca, as well as stock ownership of CEERVA. EC Rossi reports personal fees from Intuitive Surgical, Inc. JW Davis reports personal fees from Intuitive Surgical, Inc. and research funding from Janssem. GJ Chang reports personal fees from Medicaroid. DC Rice reports personal fees and research funding from Intuitive Surgical, Inc.

Figures

Figure 1.
Figure 1.. Cervical Cancer Forest Plots.
Forest plots showing hazard ratios for individual papers as well as pooled outcomes for cervical cancer for A) incidence of recurrence for RAS vs OPEN, B) disease-free survival (DFS) for RAS vs LAP, and C) for RAS vs OPEN, D) overall survival (OS) for RAS vs LAP, and E) for RAS vs OPEN. RAS=robotic-assisted surgery, LAP=laparoscopy, OPEN=open surgery, CI=confidence interval, BMI=body mass index, KM=Kaplan-Meier, yr=year, mo=month, HR=hazard ratio, FU=follow-up, sig=significant, diff=different, PFS=progression-free survival, calc=calculated, DOD=dead of disease, DOO=dead of other, AWD=alive with disease.
Figure 2.
Figure 2.. Endometrial Cancer Forest Plots.
Forest plots showing hazard ratios for individual papers as well as pooled outcomes for endometrial cancer for A) disease-free survival (DFS) for RAS vs. LAP, and B) for RAS vs. OPEN, C) overall survival for RAS vs. LAP, and D) for RAS vs. OPEN. RAS=robotic-assisted surgery, LAP=laparoscopy, OPEN=open surgery, CI=confidence interval, BMI=body mass index, KM=Kaplan-Meier, yr=year, mo=month, HR=hazard ratio, FU=follow-up, sig=significant, diff=different, PFS=progression-free survival, calc=calculated, DOD=dead of disease, DOO=dead of other, AWD=alive with disease.
Figure 3.
Figure 3.. Lobectomy for Lung Cancer Forest Plots.
Forest plots showing hazard ratios for individual papers as well as pooled outcomes for lobectomy for lung cancer for A) disease-free survival (DFS) for RAS vs. VATS, and B) for RAS vs. OPEN, C) overall survival (OS) for RAS vs. VATS, and D) for RAS vs. OPEN. RAS=robotic-assisted surgery, VATS=video-assisted thoracoscopic surgery, OPEN=open surgery, CI=confidence interval, KM=Kaplan-Meier, ref=reference group, sig=significant, diff=different, clin=clinical, pt=patient.
Figure 4.
Figure 4.. Prostatectomy Forest Plots.
Forest plots showing hazard ratios for individual papers as well as pooled outcomes for prostate cancer for A) Biochemical-recurrence (BCR) for RAS vs. LAP (BCR for RAS vs. OPEN is in Supplementary Figure 7), B) BCR-Free Survival (BCRFS) for RAS vs. LAP and for C) RAS vs. OPEN, D) Overall Survival (OS) for RAS vs. LAP and for E) RAS vs. OPEN. RAS=robotic-assisted surgery, LAP=laparoscopy, OPEN=open surgery, CI=confidence interval, KM=Kaplan-Meier, GS=gleason score, NS=not significant, yr=year, mo=month, HR=hazard ratio, ref=reference group, sig=significant, calc=calculated.
Figure 5.
Figure 5.. Forest Plots for Low-Anterior Resection for Rectal Cancer.
Forest plots of hazard ratios for low-anterior resection for rectal cancer. A) local recurrence RAS vs. LAP, and B) for RAS vs. OPEN, C) Disease-Free Survival (DFS) for RAS vs. LAP, and D) for RAS vs. OPEN, E) Overall Survival (OS) for RAS vs. LAP, and F) for RAS vs. OPEN.

References

    1. Janda M, Gebski V, Davies LC, et al. Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage I endometrial cancer: a randomized clinical trial. JAMA 2017;317(12):1224–1233. - PubMed
    1. Kornblith AB, Huang HQ, Walker JL, Spirtos NM, Rotmensch J, Cella D. Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study. J Clin Oncol 2009;27(32):5337–5342. - PMC - PubMed
    1. Walker JL, Piedmonte MR, Spirtos NM, et al. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study. J Clin Oncol 2012;30(7):695–700. - PMC - PubMed
    1. Walker JL, Piedmonte MR, Spirtos NM, et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol 2009;27(32):5331–5336. - PMC - PubMed
    1. Fleshman J, Branda M, Sargent DJ, et al. Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: The ACOSOG Z6051 randomized clinical trial. JAMA 2015;314(13):1346–1355. - PMC - PubMed